SCHERING-PLOUGH PHARMACEUTICAL PRESIDENT CONKLIN TO HEAD OTC GROUP
This article was originally published in The Tan Sheet
Executive Summary
SCHERING-PLOUGH PHARMACEUTICAL PRESIDENT CONKLIN TO HEAD OTC GROUP under a top-level management reshuffling announced on July 7. Effective Sept. 1, Schering-Plough Exec VP Donald Conldin, 57, who has directed the company's worldwide prescription drug business since 1986, will become president of Schering-Plough HealthCare, replacing David Collins.